Evidence map›Paper›PMID 40072186›Full record

ArticleNanomaterials (Basel, Switzerland)2025

Photocatalytic Degradation of Ciprofloxacin by GO/ZnO/Ag Composite Materials.

Haonan Chi, Pan Cao, Qi Shi, Chaoyu Song, Yuguang Lv, Tai Peng

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Microwave-Assisted Green Synthesis of BiChemistry & biodiversity · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haonan ChiSchool of Materials Science and Engineering, Jiamusi University, Jiamusi 154000, China.
Pan CaoCollege of Pharmacy, Jiamusi University, Jiamusi 154000, China.
Qi ShiSchool of Materials Science and Engineering, Jiamusi University, Jiamusi 154000, China.
Chaoyu SongSchool of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Yuguang LvSchool of Materials Science and Engineering, Jiamusi University, Jiamusi 154000, China.
Tai PengSchool of Materials Science and Engineering, Jiamusi University, Jiamusi 154000, China.ORCID 0000-0002-1934-8184

Funding

2023 Jiamusi University National Foundation Incubation Program JMSUGPZR2023-006the Department of Scientific Research projectin Heilong jiang province No. LH2022B022the Department of Scientific Research project in the Basic Scientific Research Funds of Heilongjiang Provincial Colleges and Universities No. 2023-KYYWF-0594
6 · The paper itself

Abstract

This study synthesized graphene oxide (GO)/zinc oxide (ZnO)/silver (Ag) composite materials and investigated their photocatalytic degradation performance for ciprofloxacin (CIP) under visible light irradiation. GO/ZnO/Ag composites with different ratios were prepared via an impregnation and chemical reduction method and characterized using X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FT-IR), and X-ray photoelectron spectroscopy (XPS). The results demonstrated that under optimal conditions (20 mg/L CIP concentration, 15 mg catalyst dosage, GO/ZnO-3%/Ag-doping ratio, and pH 5), the GO/ZnO/Ag composite exhibited the highest photocatalytic activity, achieving a maximum degradation rate of 82.13%. This catalyst effectively degraded ciprofloxacin under light irradiation, showing promising potential for water purification applications.

Indexed as

ciprofloxacingraphene oxidephotocatalytic degradationsilverultraviolet rayszinc oxide

Identifiers

PMID40072186
PMCPMC11901575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.